High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term results.
Carella
Angelo Michele
AM
Bellei
Monica
M
Brice
Pauline
P
Gisselbrecht
Christian
C
Visani
Giuseppe
G
Colombat
Philippe
P
Fabbiano
Francesco
F
Donelli
Amedea
A
Luminari
Stefano
S
Feugier
Pierre
P
Browett
Peter
P
Hagberg
Hans
H
Federico
Massimo
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D006801:Humans; D009367:Neoplasm Staging; D033581:Stem Cell Transplantation; D015996:Survival Rate; D013997:Time Factors; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents